Press Releases Moberg Pharma AB

Equities

MOB

SE0020353928

Market Closed - Nasdaq Stockholm Other stock markets 11:29:44 2024-04-26 am EDT			5-day change	1st Jan Change
33.16 ^SEK	-2.87%		+7.94%	+118.16%

Apr. 08	Moberg Pharma AB Submits Application to Include an Additional Terbinafine Supplier	CI
Feb. 26	Certain Ordinary Shares of Moberg Pharma AB are subject to a Lock-Up Agreement Ending on 26-FEB-2024.	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Moberg Pharma : Launch update for MOB-015	Apr. 23	PU
Moberg Pharma : Launch update for MOB-015	Apr. 23	PU
Notice of Annual General Meeting in Moberg Pharma AB (publ)	Apr. 12	AQ
Moberg Pharma Annual report for 2023	Apr. 12	AQ
Moberg Pharma : Corporate Governance Report 2023	Apr. 12	PU
Moberg Pharma : Application submitted to include an additional terbinafine supplier	Apr. 08	PU
The Nomination Committee's proposal to the Annual General Meeting 2024	Feb. 19	AQ
MOB-015 is launched in Sweden under the brand name Terclara- pharmacies report major demand for the new medication	Feb. 07	AQ
Moberg Pharma's Interim report January - September 2023	Nov. 07	AQ
Moberg Pharma strengthens the organization	Nov. 07	AQ
Moberg Pharma's Nomination Committee appointed	23-10-17	AQ
MOBERG PHARMA HAS COMPLETED ENROLLMENT TO THE PHASE 3 STUDY FOR MOB-015 IN NORTH AMERICA	23-10-09	AQ
Bulletin from Moberg Pharma's Extraordinary General Meeting	23-10-09	AQ
Moberg Pharma has completed enrollment to the Phase 3 study for MOB-015 in North America	23-10-06	AQ
New number of shares and votes in Moberg Pharma AB (publ)	23-09-29	AQ
Notice of Extraordinary General Meeting in Moberg Pharma AB (publ)	23-09-13	AQ
Clarification regarding directed issue of units to guarantors in connection with the completed rights issue	23-09-13	AQ
Moberg Pharma resolves a directed issue of units to guarantors in connection with the completed rights issue	23-09-08	AQ
Moberg Pharma's rights issue of MSEK 100 is oversubscribed - subscription rate 130%	23-09-01	AQ
MOBERG PHARMA PUBLISHES PROSPECTUS RELATING TO THE RIGHTS ISSUE	23-08-14	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Moberg Pharma AB

Equities

MOB

SE0020353928

Press Releases

Filters